Pavan Madan, MD

Long-Term Treatment Response in Pediatric OCD

March 12, 2021

Pavan Madan, MD Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Which is better for OCD in children and adolescents: Cognitive Behavioral Therapy (CBT), Serotonin Specific Reuptake Inhibitors or a combination of both in children and adolescents? Are there reasonable options between these choices? This research review gives some helpful answers that you can put into practice with your patients today.

Adolescents and Sleep: Parents Can Make a Difference

May 7, 2020

Pavan Madan, MD

Pavan Madan, MD Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Can parents impact teen sleep in a helpful manner? Teens are notorious for staying up late and having trouble getting up in the morning. We are often asked to opine on this problem. This research review looks at the effect of such intervention, including the consideration of the difference between a ‘significant finding’ and one that is clinically meaningful.

Engage Those Infants: Maternal Interaction and Autism

November 21, 2019

Pavan Madan, MD

Pavan Madan, MD Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

More and more research points to the central importance of supporting better caregiver-child relationships in the treatment of Autism Spectrum Disorder. Read this article to hear about the impact of maternal efforts to engage high and low risk infants.

Weight Gain From Aripiprazole Same as Risperidone

November 21, 2019

Pavan Madan, MD

Pavan Madan, MD Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Weight gain is a common side effect of antipsychotic treatment in children and adolescents. Is one medication less problematic than another? This article reports on a comparison between risperidone and aripiprazole. The results might surprise you.

Risk of Psychosis With Stimulants in ADHD Patients

June 11, 2019

Pavan Madan, MD

Pavan Madan, MD Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

As of 2007, the FDA requires stimulant manufacturers to warn of possible psychosis with stimulant use. This article analyzes the results of a 2019 study comparing the risk of psychosis between methylphenidate and amphetamine classes of medications.

Is Watching ‘13 Reasons Why’ Bad for Teens?

March 13, 2019

Pavan Madan, MD

Pavan Madan, MD

13 Reasons Why, a popular Netflix series, stirred controversy when it portrayed the bullying and suicide of a teenager. Although the program increased awareness of these issues, some clinicians argued that it glamorized suicide and would be detrimental to vulnerable viewers.

Cannabis and the Endocannabinoid System

June 1, 2014

Tisa Adkinson, DO and Pavan Madan, MD

Tisa Adkinson, DO Child and Adolescent and Addiction Psychiatrist, CARES, the Child and Family Institute, New York, NY Dr. Adkinson has disclosed that she has no relevant relationships or commercial interests in any companies related to this educational activity. Pavan Madan, MD Child and Adolescent Psychiatry Fellow, Mount Sinai St. Luke’s-Roosevelt Hospital Center, New York, NY Dr. Madan has disclosed that he has no relevant relationships or commercial interests in any companies related to this educational activity.

Considering the increased efforts to legalize marijuana in many states, greater public awareness of marijuana and its potential medicinal uses, and new research on cannabis and its constituents, it is essential that psychiatrists understand some of its proposed benefits—and fundamental risks.

Dealing With Side Effects of SSRIs

May 1, 2014

Pavan Madan, MD

Selective serotonin reuptake inhibitors (SSRIs) are widely used as the first-line treatment for depression and anxiety in children and adolescents, but they are associated with significant adverse effects (AEs). Studies have shown that up to 50% of kids experience side effects from SSRIs, depending on the sample size and the type of study.